31748-44-4 Usage
General Description
1-METHYL-1H-INDAZOLE-3-CARBONITRILE is a chemical compound with the molecular formula C9H7N3. It is classified as an indazole derivative and contains a cyano group, which is a functional group consisting of a carbon atom triple-bonded to a nitrogen atom. 1-METHYL-1H-INDAZOLE-3-CARBONITRILE is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. It also has potential applications in material science and organic chemistry. Additionally, it is important to handle this chemical with proper care, as it may pose health and environmental hazards if not managed responsibly.
Check Digit Verification of cas no
The CAS Registry Mumber 31748-44-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,7,4 and 8 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 31748-44:
(7*3)+(6*1)+(5*7)+(4*4)+(3*8)+(2*4)+(1*4)=114
114 % 10 = 4
So 31748-44-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H7N3/c1-12-9-5-3-2-4-7(9)8(6-10)11-12/h2-5H,1H3
31748-44-4Relevant articles and documents
Azaindoles
-
Page/Page column 117-118, (2008/06/13)
The invention is directed to compositions containing physiologically active compounds of general formula (I): wherein R1 is aryl or heteroaryl; R2 represents hydrogen, acyl, cyano, halo, lower alkenyl or lower alkyl optionally substituted by a substituent selected from cyano, heteroaryl, heterocycloalkyl, —Z1R8, —C(═O)—NY3Y4, —CO2R8, —NY3Y4, —N(R6)—C(═O)—R7, —N(R6)—C(═O)—NY3Y4, —N(R6)—C(═O)—OR7, —N(R6)—SO2—R7, —N(R6)—SO2—NY3Y4 and one or more halogen a toms ; R3 represents hydrogen, aryl, cyano, halo, heteroaryl, lower alkyl, —C(═O)—OR5 or —C(═O)—NY3Y; and X1 represents N, CH, C-halo, C—CN, C—R7, C—NY3Y4, C—OH, C—Z2R7, C—C(═O)—OR5, C—C(═O)—NY3Y4, C—N(R8)—C(═O)—R7, C—SO2—NY3Y4, C—N(R8)—SO2—R7, C-alkenyl, C-alkynyl or C—NO2; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
